Lin‐Hui Su
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.2%
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 49
- Epidemiology 35
- Pneumonia and Respiratory Infections 18
- Pneumocystis jirovecii pneumonia detection and treatment 9
- Co-authors
- Cheng‐Hsun Chiu (47 shared papers)Chishih Chu (19 shared papers)Tsu‐Lan Wu (40 shared papers)Ju‐Hsin Chia (22 shared papers)An-Jing Kuo (21 shared papers)Jien-Wei Liu (13 shared papers)Chien‐Jen Chen (4 shared papers)Chen‐Hsiang Lee (10 shared papers)
- Journals
- Journal of Microbiology Immunology and Infection (11 papers)Microbial Drug Resistance (8 papers)Journal of Clinical Microbiology (8 papers)International Journal of Antimicrobial Agents (7 papers)Emerging infectious diseases (5 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Lin‐Hui Su
111 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 127
- Molecular Medicine 1.3k
- Endocrinology 1.0k
- Applied Microbiology and Biotechnology 146
- Food Science 1.0k
- Infectious Diseases 706
Countries citing papers authored by Lin‐Hui Su
This map shows the geographic impact of Lin‐Hui Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Hui Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Hui Su more than expected).
Fields of papers citing papers by Lin‐Hui Su
This network shows the impact of papers produced by Lin‐Hui Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Hui Su. The network helps show where Lin‐Hui Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin‐Hui Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 216 | |
| 2 | 2013 | 211 | |
| 3 | 1999 | 205 | |
| 4 | 2007 | 123 | |
| 5 | 2009 | 95 | |
| 6 | Salmonella: clinical importance and evolution of nomenclature. | 2007 | 93 |
| 7 | 2007 | 86 | |
| 8 | 2005 | 84 | |
| 9 | 2005 | 72 | |
| 10 | 2010 | 72 | |
| 11 | 2007 | 71 | |
| 12 | 2006 | 69 | |
| 13 | 2019 | 67 | |
| 14 | 2006 | 64 | |
| 15 | 2003 | 64 | |
| 16 | 2004 | 60 | |
| 17 | 2003 | 57 | |
| 18 | 2016 | 55 | |
| 19 | 2010 | 52 | |
| 20 | Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004. | 2008 | 51 |
About Lin‐Hui Su
Lin‐Hui Su is a scholar working on Molecular Medicine, Epidemiology, Endocrinology, Infectious Diseases and Food Science, having authored 111 papers that have together received 3.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (49 papers), Salmonella and Campylobacter epidemiology (28 papers), Vibrio bacteria research studies (19 papers), Pneumonia and Respiratory Infections (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Bacterial biofilms and quorum sensing (13 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (9 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Endocrinology (1.0k citations), Applied Microbiology and Biotechnology (146 citations), Food Science (1.0k citations) and Infectious Diseases (706 citations). Lin‐Hui Su has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Cheng‐Hsun Chiu, Chishih Chu, Tsu‐Lan Wu, Ju‐Hsin Chia, An-Jing Kuo, Jien-Wei Liu, Chien‐Jen Chen, Chen‐Hsiang Lee, Yue Wang and Hung-Ming Chen. Their work appears in journals such as Journal of Microbiology Immunology and Infection, Microbial Drug Resistance, Journal of Clinical Microbiology, International Journal of Antimicrobial Agents and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.